Why cash-pay is often cheaper than insurance for specialty drugs
When a specialty drug has a high deductible, a coinsurance ladder, and a US WAC several multiples over the international price, cash-pay abroad can be the lower number.
Who this is for
When a specialty drug has a high deductible, a coinsurance ladder, and a US WAC several multiples over the international price, cash-pay abroad can be the lower number. This guide is written for international cash-pay patients and their families, the home-country oncologists and rare-disease specialists who sign the prescription, and the family-office and concierge teams who handle the wires. It is not a substitute for licensed financial advice or for a treating-physician conversation; it is a working map of how the money actually moves on a specialty drug procurement.
How the money typically moves
The dominant pattern is patient prepay to a US specialty pharmacy after a firm written quote. A patient or sponsor signs an intake, confirms indication and destination, and receives a quote that breaks out drug cost, handling, cold-chain, customs and broker fees. On approval, the patient wires the full amount; the pharmacy ships only after funds clear and DSCSA paperwork is in place. Refunds, where granted, follow a narrow set of failure modes: procurement failure or gross negligence. Delivery or transit failures are typically replaced rather than refunded, with the insurance carrier picking up the loss.
Why prepayment, not escrow
Escrow looks reassuring on paper but introduces a regulated third party between the patient and the pharmacy. In practice, escrow extends the timeline by 5-10 business days, raises legal-fee exposure for both sides, and rarely changes outcomes. A clean prepay model, with a written quote, an itemised refund clause, and an insurance backstop on transit, performs better in practice.
Common mistakes
Three recur: paying without a written refund clause, treating an indicative range as a firm quote, and assuming a credit-card chargeback will recover a specialty drug payment, which it almost never does on six-figure international wires. A fourth, less visible, is failing to align the bank wire with the patient name on the prescription; many specialty pharmacies will hold a shipment when the sender does not match the patient of record.
What to ask your bank
For wires above USD 100,000, ask your bank whether the destination correspondent has a same-day settlement window, whether OFAC screening is automated or manual, and what the recall policy is if the pharmacy rejects the wire. For wires above USD 1M, ask whether a forward FX contract or same-day spot-rate lock is available; a 1.5 percent FX swing on a USD 2.1M gene-therapy wire is USD 31,500.
What to ask your pharmacy
Request a written quote with lot-level drug cost, cold-chain handling, customs and broker fees, refund clause, and insurance certificate. Ask for the DEA and state-board licence numbers; cross-check both on the relevant state-board portal. Ask for a sample temperature-logger report; the absence of a recent one is a warning sign.
Tax and reporting
Personal-import medical purchases are typically deductible in countries with itemised medical-expense relief, including the US, UK and India, subject to documentation. Keep the wire receipt, the pharmacy invoice, the customs declaration, and the treating-physician prescription as a single bundle; tax authorities and private insurers ask for the same documents in different orders.
When to escalate
If the quote contains language that prevents you from auditing the supply chain, that prohibits a second-opinion review of the drug, or that waives the pharmacy's gross-negligence liability, treat it as a hard stop. A reputable operator will not require any of those clauses, and any operator that does is not worth the savings.
How Reserve Meds handles the money
Reserve Meds operates a prepay-direct-procurement model. There is no patient deposit at intake. The patient receives a firm quote post-documentation, wires 100 percent on accepting that quote, and is refunded under a narrow procurement-failure clause if the drug cannot be procured. We do not run escrow, we do not handle financing, and we do not assess patient creditworthiness. We coordinate the supply chain and the documentation. The financial relationship is between the patient or sponsor and the US specialty pharmacy of record.
Frequently asked questions
Can I pay with a credit card?
Most US specialty pharmacies require a SWIFT wire on amounts above USD 10,000; cards are accepted for small ancillary fees but not for the drug itself.
Will my insurance reimburse me afterwards?
Reimbursement is jurisdiction-specific; many private insurers in the UAE, KSA and India reimburse partially when accompanied by a treating-physician letter and customs paperwork.
Is there a discount for paying upfront?
Specialty pharmacies do not discount for prepay because they already require prepay; the question to ask is whether your operator pre-negotiates a manufacturer or wholesaler rate.
Related on Reserve Meds
Sources
- OECD - Pharmaceutical pricing policies
- WHO - Access to medicines and health products
- U.S. Food and Drug Administration - Drugs
- HHS - Health insurance and the Affordable Care Act
Start a request
Reviewed 2026-05-18 · Next review: 2026-11-18